The global market for Immunohematology Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Immunohematology Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Immunohematology Testing by region & country, by Type, and by Application.
The Immunohematology Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunohematology Testing.
麻豆原创 Segmentation
By Company
Nihon Kohden Corporation
Diasorin S.p.A.
HemaCare Corporation
Roche Diagnostics
Siemens Healthineers
Beckman Coulter, Inc.
Abbott Laboratories
Grifols, S.A.
Ortho Clinical Diagnostics
产颈辞惭茅谤颈别耻虫
Alere, Inc.
Becton, Dickinson and Company (BD)
Thermo Fisher Scientific
Diamedix Corporation
Immucor, Inc.
Agilent Technologies, Inc.
Haemonetics Corporation
Luminex Corporation
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Segment by Type:
Abo Blood Typing
Antibody Screening
Crossmatching
Direct Antiglobulin Test
Antigen Typing
Segment by Application
Transfusion Medicine
Organ and Stem Cell Transplantation
Antibody Identification and Resolution
Blood Bank Consulting
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Immunohematology Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Immunohematology Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Immunohematology Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Immunohematology Testing Product Introduction
1.2 Global Immunohematology Testing 麻豆原创 Size Forecast
1.3 Immunohematology Testing 麻豆原创 Trends & Drivers
1.3.1 Immunohematology Testing Industry Trends
1.3.2 Immunohematology Testing 麻豆原创 Drivers & Opportunity
1.3.3 Immunohematology Testing 麻豆原创 Challenges
1.3.4 Immunohematology Testing 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Immunohematology Testing Players Revenue Ranking (2023)
2.2 Global Immunohematology Testing Revenue by Company (2019-2024)
2.3 Key Companies Immunohematology Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Immunohematology Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Immunohematology Testing
2.6 Immunohematology Testing 麻豆原创 Competitive Analysis
2.6.1 Immunohematology Testing 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Immunohematology Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunohematology Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Abo Blood Typing
3.1.2 Antibody Screening
3.1.3 Crossmatching
3.1.4 Direct Antiglobulin Test
3.1.5 Antigen Typing
3.2 Global Immunohematology Testing Sales Value by Type
3.2.1 Global Immunohematology Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Immunohematology Testing Sales Value, by Type (2019-2030)
3.2.3 Global Immunohematology Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Transfusion Medicine
4.1.2 Organ and Stem Cell Transplantation
4.1.3 Antibody Identification and Resolution
4.1.4 Blood Bank Consulting
4.2 Global Immunohematology Testing Sales Value by Application
4.2.1 Global Immunohematology Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Immunohematology Testing Sales Value, by Application (2019-2030)
4.2.3 Global Immunohematology Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Immunohematology Testing Sales Value by Region
5.1.1 Global Immunohematology Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Immunohematology Testing Sales Value by Region (2019-2024)
5.1.3 Global Immunohematology Testing Sales Value by Region (2025-2030)
5.1.4 Global Immunohematology Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Immunohematology Testing Sales Value, 2019-2030
5.2.2 North America Immunohematology Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Immunohematology Testing Sales Value, 2019-2030
5.3.2 Europe Immunohematology Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Immunohematology Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Immunohematology Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Immunohematology Testing Sales Value, 2019-2030
5.5.2 South America Immunohematology Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Immunohematology Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Immunohematology Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Immunohematology Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Immunohematology Testing Sales Value
6.3 United States
6.3.1 United States Immunohematology Testing Sales Value, 2019-2030
6.3.2 United States Immunohematology Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Immunohematology Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Immunohematology Testing Sales Value, 2019-2030
6.4.2 Europe Immunohematology Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Immunohematology Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Immunohematology Testing Sales Value, 2019-2030
6.5.2 China Immunohematology Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Immunohematology Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Immunohematology Testing Sales Value, 2019-2030
6.6.2 Japan Immunohematology Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Immunohematology Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Immunohematology Testing Sales Value, 2019-2030
6.7.2 South Korea Immunohematology Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Immunohematology Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Immunohematology Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Immunohematology Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Immunohematology Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Immunohematology Testing Sales Value, 2019-2030
6.9.2 India Immunohematology Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Immunohematology Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Nihon Kohden Corporation
7.1.1 Nihon Kohden Corporation Profile
7.1.2 Nihon Kohden Corporation Main Business
7.1.3 Nihon Kohden Corporation Immunohematology Testing Products, Services and Solutions
7.1.4 Nihon Kohden Corporation Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Nihon Kohden Corporation Recent Developments
7.2 Diasorin S.p.A.
7.2.1 Diasorin S.p.A. Profile
7.2.2 Diasorin S.p.A. Main Business
7.2.3 Diasorin S.p.A. Immunohematology Testing Products, Services and Solutions
7.2.4 Diasorin S.p.A. Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Diasorin S.p.A. Recent Developments
7.3 HemaCare Corporation
7.3.1 HemaCare Corporation Profile
7.3.2 HemaCare Corporation Main Business
7.3.3 HemaCare Corporation Immunohematology Testing Products, Services and Solutions
7.3.4 HemaCare Corporation Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Roche Diagnostics Recent Developments
7.4 Roche Diagnostics
7.4.1 Roche Diagnostics Profile
7.4.2 Roche Diagnostics Main Business
7.4.3 Roche Diagnostics Immunohematology Testing Products, Services and Solutions
7.4.4 Roche Diagnostics Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Roche Diagnostics Recent Developments
7.5 Siemens Healthineers
7.5.1 Siemens Healthineers Profile
7.5.2 Siemens Healthineers Main Business
7.5.3 Siemens Healthineers Immunohematology Testing Products, Services and Solutions
7.5.4 Siemens Healthineers Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Siemens Healthineers Recent Developments
7.6 Beckman Coulter, Inc.
7.6.1 Beckman Coulter, Inc. Profile
7.6.2 Beckman Coulter, Inc. Main Business
7.6.3 Beckman Coulter, Inc. Immunohematology Testing Products, Services and Solutions
7.6.4 Beckman Coulter, Inc. Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Beckman Coulter, Inc. Recent Developments
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Profile
7.7.2 Abbott Laboratories Main Business
7.7.3 Abbott Laboratories Immunohematology Testing Products, Services and Solutions
7.7.4 Abbott Laboratories Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Abbott Laboratories Recent Developments
7.8 Grifols, S.A.
7.8.1 Grifols, S.A. Profile
7.8.2 Grifols, S.A. Main Business
7.8.3 Grifols, S.A. Immunohematology Testing Products, Services and Solutions
7.8.4 Grifols, S.A. Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Grifols, S.A. Recent Developments
7.9 Ortho Clinical Diagnostics
7.9.1 Ortho Clinical Diagnostics Profile
7.9.2 Ortho Clinical Diagnostics Main Business
7.9.3 Ortho Clinical Diagnostics Immunohematology Testing Products, Services and Solutions
7.9.4 Ortho Clinical Diagnostics Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Ortho Clinical Diagnostics Recent Developments
7.10 产颈辞惭茅谤颈别耻虫
7.10.1 产颈辞惭茅谤颈别耻虫 Profile
7.10.2 产颈辞惭茅谤颈别耻虫 Main Business
7.10.3 产颈辞惭茅谤颈别耻虫 Immunohematology Testing Products, Services and Solutions
7.10.4 产颈辞惭茅谤颈别耻虫 Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.10.5 产颈辞惭茅谤颈别耻虫 Recent Developments
7.11 Alere, Inc.
7.11.1 Alere, Inc. Profile
7.11.2 Alere, Inc. Main Business
7.11.3 Alere, Inc. Immunohematology Testing Products, Services and Solutions
7.11.4 Alere, Inc. Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.11.5 Alere, Inc. Recent Developments
7.12 Becton, Dickinson and Company (BD)
7.12.1 Becton, Dickinson and Company (BD) Profile
7.12.2 Becton, Dickinson and Company (BD) Main Business
7.12.3 Becton, Dickinson and Company (BD) Immunohematology Testing Products, Services and Solutions
7.12.4 Becton, Dickinson and Company (BD) Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.12.5 Becton, Dickinson and Company (BD) Recent Developments
7.13 Thermo Fisher Scientific
7.13.1 Thermo Fisher Scientific Profile
7.13.2 Thermo Fisher Scientific Main Business
7.13.3 Thermo Fisher Scientific Immunohematology Testing Products, Services and Solutions
7.13.4 Thermo Fisher Scientific Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.13.5 Thermo Fisher Scientific Recent Developments
7.14 Diamedix Corporation
7.14.1 Diamedix Corporation Profile
7.14.2 Diamedix Corporation Main Business
7.14.3 Diamedix Corporation Immunohematology Testing Products, Services and Solutions
7.14.4 Diamedix Corporation Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.14.5 Diamedix Corporation Recent Developments
7.15 Immucor, Inc.
7.15.1 Immucor, Inc. Profile
7.15.2 Immucor, Inc. Main Business
7.15.3 Immucor, Inc. Immunohematology Testing Products, Services and Solutions
7.15.4 Immucor, Inc. Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.15.5 Immucor, Inc. Recent Developments
7.16 Agilent Technologies, Inc.
7.16.1 Agilent Technologies, Inc. Profile
7.16.2 Agilent Technologies, Inc. Main Business
7.16.3 Agilent Technologies, Inc. Immunohematology Testing Products, Services and Solutions
7.16.4 Agilent Technologies, Inc. Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.16.5 Agilent Technologies, Inc. Recent Developments
7.17 Haemonetics Corporation
7.17.1 Haemonetics Corporation Profile
7.17.2 Haemonetics Corporation Main Business
7.17.3 Haemonetics Corporation Immunohematology Testing Products, Services and Solutions
7.17.4 Haemonetics Corporation Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.17.5 Haemonetics Corporation Recent Developments
7.18 Luminex Corporation
7.18.1 Luminex Corporation Profile
7.18.2 Luminex Corporation Main Business
7.18.3 Luminex Corporation Immunohematology Testing Products, Services and Solutions
7.18.4 Luminex Corporation Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.18.5 Luminex Corporation Recent Developments
7.19 Bio-Rad Laboratories, Inc.
7.19.1 Bio-Rad Laboratories, Inc. Profile
7.19.2 Bio-Rad Laboratories, Inc. Main Business
7.19.3 Bio-Rad Laboratories, Inc. Immunohematology Testing Products, Services and Solutions
7.19.4 Bio-Rad Laboratories, Inc. Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.19.5 Bio-Rad Laboratories, Inc. Recent Developments
7.20 Sysmex Corporation
7.20.1 Sysmex Corporation Profile
7.20.2 Sysmex Corporation Main Business
7.20.3 Sysmex Corporation Immunohematology Testing Products, Services and Solutions
7.20.4 Sysmex Corporation Immunohematology Testing Revenue (US$ Million) & (2019-2024)
7.20.5 Sysmex Corporation Recent Developments
8 Industry Chain Analysis
8.1 Immunohematology Testing Industrial Chain
8.2 Immunohematology Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Immunohematology Testing Sales Model
8.5.2 Sales Channel
8.5.3 Immunohematology Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Nihon Kohden Corporation
Diasorin S.p.A.
HemaCare Corporation
Roche Diagnostics
Siemens Healthineers
Beckman Coulter, Inc.
Abbott Laboratories
Grifols, S.A.
Ortho Clinical Diagnostics
产颈辞惭茅谤颈别耻虫
Alere, Inc.
Becton, Dickinson and Company (BD)
Thermo Fisher Scientific
Diamedix Corporation
Immucor, Inc.
Agilent Technologies, Inc.
Haemonetics Corporation
Luminex Corporation
Bio-Rad Laboratories, Inc.
Sysmex Corporation
听
听
*If Applicable.
